from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0493c/-

LFCtreatmentdescriptionclass of inhibitor

0.386

Amikacinug/mL Amikacintranslation

-0.629

Cap5-10ug/mL Capreomycintranslation

-0.617

Rox10-50 ug/mL Roxithromycintranslation

-0.661

SM2-5 ug/mL Streptomycintranslation

0.086

Tet5-10 ug/mL Tetracyclinetranslation

0.959

Rif0.2-5ug/mL Rifampicintranscription

0.564

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.836

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.613

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.170

CPZ10-50 ug/mL Chlorpromazinerespiration

0.604

Clofazimine10-13 ug/mL Clofaziminerespiration

0.485

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.525

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.437

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.097

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.422

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.118

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.716

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.289

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.062

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.458

KCN5-20 ug/mL Potassium cyaniderespiration

-0.626

NaN30.2-2 mM Sodium aziderespiration

-0.373

Nigericin50 uM Nigericinrespiration

0.414

TRC10-150 ug/mL Triclosanrespiration

1.931

TRZ10-25 ug/mL Thioridazinerespiration

-0.876

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.548

menadione6-10 ug/mL Menadionerespiration

0.049

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.023

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.384

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.093

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.017

NRP_1Non-replicating persistence stage 1dosRassociated

-0.417

Amp0.2mg/mL AmpicillincellWall

0.016

Cephalexin20-100 ug/mL CephalexincellWall

-0.808

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.402

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.143

EMB10-20 ug/mL EthambutolcellWall

-0.136

Eta12-40 ug/mL EthionamidecellWall

-0.181

INH0.2-0.4 ug/mL IsoniazidcellWall

0.209

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.224

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.295

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.042

BZA0.12 mg/mL BenzamidearomaticAmides

-0.206

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.583

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.400

H2O24 mM hydrogen peroxideDNAdamaging

-0.049

Levo10 ug/mL LevofloxacinDNAdamaging

-0.836

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.413

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.279

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.916

UVUV-irradiationDNAdamaging

1.033

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.369

Antimycin12.5-50 ug/mL Antimycin A?

-0.355

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.011

PA_110-50 ug/mL Antitubercular compound PA-1?

0.355

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.666

PA8240.2-2 ug/mL PA-824?

0.644

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.198

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.741

Verapamil50 uM Verapamil?

-0.074

mercaptoethanol2 mM 2-Mercaptoethanol?

0.735

methoxatin10-20 ug/mL Methoxatin?